KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other financing activities (2017 - 2025)

Exact Sciences (EXAS) has disclosed Other financing activities for 9 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 21.76% to -$1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.9 million through Dec 2025, up 33.05% year-over-year, with the annual reading at -$11.9 million for FY2025, 33.05% up from the prior year.
  • Other financing activities for Q4 2025 was -$1.7 million at Exact Sciences, up from -$1.7 million in the prior quarter.
  • The five-year high for Other financing activities was -$417000.0 in Q4 2022, with the low at -$11.6 million in Q2 2024.
  • Average Other financing activities over 5 years is -$2.5 million, with a median of -$1.7 million recorded in 2021.
  • The sharpest move saw Other financing activities tumbled 903.64% in 2024, then surged 84.13% in 2025.
  • Over 5 years, Other financing activities stood at -$544000.0 in 2021, then increased by 23.35% to -$417000.0 in 2022, then tumbled by 443.65% to -$2.3 million in 2023, then increased by 2.51% to -$2.2 million in 2024, then rose by 21.76% to -$1.7 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$1.7 million, -$1.7 million, and -$1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.